Use of drotrecogin alfa (activated) in a severe acute respiratory syndrome patient with severe sepsis

被引：1
|
作者：
McRitchie, Donna [1 ]
Farooq, Warda [1 ]
Fisher, Harold N. [2 ]
机构：
[1] Univ Toronto, N York Gen Hosp, Toronto, ON, Canada
[2] Eli Lilly Canada Inc, Toronto, ON, Canada
来源：
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY | 2008年 / 19卷 / 03期
关键词：
D O I：
10.1155/2008/501759
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：258 / 259
页数：2
相关论文
共 50 条
  • [31] Drotrecogin alfa (Activated) for the treatment of severe sepsis and septic shock
    Rice, TW
    Bernard, GR
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 328 (04): : 205 - 214
  • [32] Drotrecogin alfa activated as a treatment for severe sepsis in pediatric cancer
    Russo, G.
    La Spina, M.
    Disma, N.
    Astuto, M.
    BONE MARROW TRANSPLANTATION, 2006, 38 (08) : 575 - 576
  • [33] The safety of drotrecogin alfa (activated) in pediatric patients with severe sepsis
    Goldstein, B
    Williams, M
    Wang, DZ
    Angle, R
    Giroir, B
    CRITICAL CARE MEDICINE, 2005, 33 (12) : A152 - A152
  • [34] The efficacy of drotrecogin alfa (activated) for the treatment of pediatric severe sepsis
    Giroir, B
    Goldstein, B
    Nadel, S
    Wang, DZ
    Levy, H
    Williams, M
    CRITICAL CARE MEDICINE, 2005, 33 (12) : A152 - A152
  • [35] Drotrecogin alfa activated as a treatment for severe sepsis in pediatric cancer
    G Russo
    M La Spina
    N Disma
    M Astuto
    Bone Marrow Transplantation, 2006, 38 : 575 - 576
  • [36] Management of patients with severe sepsis, treated by drotrecogin alfa (activated)
    Laterre, PF
    Heiselman, D
    AMERICAN JOURNAL OF SURGERY, 2002, 184 (6A): : 39S - 46S
  • [37] Drotrecogin alfa (activated): a novel therapeutic strategy for severe sepsis
    Pastores, SM
    POSTGRADUATE MEDICAL JOURNAL, 2003, 79 (927) : 5 - 10
  • [38] Selecting patients with severe sepsis for drotrecogin alfa (activated) therapy
    Sollet, JP
    Garber, GE
    AMERICAN JOURNAL OF SURGERY, 2002, 184 (6A): : 11S - 18S
  • [39] Drotrecogin alfa (activated) in severe sepsis after cardiac surgery
    Bubenek, S.
    Stelian, E.
    Craciun, M.
    Miclea, I.
    Sefu, F.
    Boros, C.
    Timofiev, L.
    Tulbure, D.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2004, 21 : 167 - 168
  • [40] The results of the national program of drotrecogin alfa (activated) use in patients with severe sepsis in Poland
    Kubler, A
    Durek, G
    Mayzner-Zawadzka, E
    Majak, P
    CRITICAL CARE MEDICINE, 2005, 33 (12) : A150 - A150
12345